Biogennix LLC is a leading provider of advanced synthetic bone graft products, dedicated to enhancing patient outcomes in orthopedic and spine surgery. Their innovative TrelCor technology combines nanotechnology with a biomimetic composition and structure, revolutionizing the bone regeneration process.
With a focus on cutting-edge technology and advanced biologic concepts, Biogennix offers a range of products including Agilon, Morpheus, osteoSPAN, and the DirectCell System, all designed to meet the specific needs of surgeons. Committed to improving patient care, Biogennix continues to innovate and achieve clinical success in the field of bone graft technology.
Generated from the website